Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting ...
Last week, NPR’s "All Things Considered" covered an unusual topic: Scientific conference posters. For the first time in decades, scientists are rethinking the traditional design of the posters they ...
POSTERS AT THE 2018 American Association of Diabetes Educators (AADE) Annual Conference covered updates on new therapies and technology, strategies to help patients overcome fear of using insulin, and ...
If I had the time and money, I could probably go to a conference on some topic related to my research interests every month or two. Some of us flock to as many conferences as possible; others avoid ...
Antisense Therapeutics, an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need in rare diseases announces a virtual poster presentation on the ...
PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free technology, today announced their upcoming poster presentation on November 13, ...
MENDHAM, NJ, June 11, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. (“Antios”) today announced that the Company is presenting in vitro and Phase 1a data on ATI-2173, a liver targeting Active Site ...
A copy of the presentation materials can be accessed on the Events and Presentations section of the Catalyst website on the day of the presentation. MarzAA, a next-generation recombinant Factor VIIa ...
Fernanda Morales Berstein Oral presentation. Jul 2024 UKEMS 2024 annual meeting in Bath, UK (oral presentation as an invited speaker) Fernanda Morales Berstein Oral presentation. Jun 2024 6th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback